Catalyst Capital Advisors LLC Pfizer Inc Transaction History

Catalyst Capital Advisors LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2022 Feb 07, 2023	SELL	$41.75 - $54.5 $106,462 - $138,975	-2,550 Reduced 2.82%	88,000 $4.51 Million
Q3 2022 Nov 08, 2022	SELL	$43.76 - $53.42 $94,084 - $114,853	-2,150 Reduced 2.32%	90,550 $3.96 Million
Q2 2022 Aug 09, 2022	BUY	$46.53 - $55.17 $4.31 Million - $5.11 Million	92,700 New	92,700 $4.86 Million
Q2 2019 Aug 08, 2019	SELL	$36.98 - $41.52 $14.8 Million - $16.6 Million	-400,000 Closed	0 $0
Q1 2019 May 08, 2019	SELL	$37.5 - $41.2 $630,000 - $692,160	-16,800 Reduced 4.03%	400,000 $17 Million
Q4 2018 Feb 07, 2019	BUY	$38.47 - $43.86 $8.53 Million - $9.73 Million	221,800 Added 113.74%	416,800 $18.2 Million
Q3 2018 Nov 08, 2018	BUY	$34.47 - $41.81 $6.72 Million - $8.15 Million	195,000 New	195,000 $8.59 Million

3,260

3.61B

77.2M

122M

Ticker PFE
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 5,612,349,952
Market Cap $148B
Description
Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...

Get notified when there are updates to the investment portfolio of Catalyst Capital Advisors LLC, based on Form 13F filings with the SEC.

Stay updated on Catalyst Capital Advisors LLC with notifications on news.